Copay Accumulators & Maximizers

This whitepaper outlines how copay cards were intended to address patient affordability concerns and how copay accumulators and maximizers impact that process. However, there are steps brand leaders can take to reduce exposure to these programs....
Read More

Digital Health in Pharma

This whitepaper outlines how copay cards were intended to address patient affordability concerns and how copay accumulators and maximizers impact that process. However, there are steps brand leaders can take to reduce exposure to these programs....
Read More

IO Landscape

IO Landscape Over 50,000 cancer patients needed for IO trials, but will it make a dent?We are in the midst of an explosion of clinical targets within the immuno-oncology field which has resulted in impactful advancements in cancer care. ...
Read More
Consulting engagements

Getting the Most of Consulting Engagements

A consultant should be someone who provides expert advice professionally. Engaging a consultant provides access to deeper levels of expertise than would be financially feasible to retain in‐house on a long‐term basis. Organizations can control expenses and risk by purchasing as much service as d...
Read More
Innovation Pharma Sees Drop 2016

Innovation in Pharma

Innovation in the pharmaceutical industry has a dramatic impact on the health, wellness, and pocket books of millions of people. It improves quality of life, extends life time, saves lives, and can spur vigorous political debate. Historically, innovation has meant drug or treatment development. Due ...
Read More
Performance Metrics point view

Performance Metrics Point of View

A robust data strategy is essential to optimal commercial performance. However, most companies use dashboards that provide only a limited set of lagging indicators of performance with little information to guide diagnostics. A new approach to performance metrics can provide both predictive and diagn...
Read More